M&A Deal Summary

WIL Research Co. Acquires Midwest BioResearch

On February 13, 2009, WIL Research Co. acquired life science company Midwest BioResearch

Acquisition Highlights
  • This is WIL Research Co.’s 3rd transaction in the Life Science sector.
  • This is WIL Research Co.’s 2nd transaction in the United States.
  • This is WIL Research Co.’s 1st transaction in Illinois.

M&A Deal Summary

Date 2009-02-13
Target Midwest BioResearch
Sector Life Science
Buyer(s) WIL Research Co.
Deal Type Add-on Acquisition

Target

Midwest BioResearch

Skokie, Illinois, United States
Midwest BioResearch LLC provides drug disposition and toxicology services.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

WIL Research Co.

Ashland, Ohio, United States

Category Company
Founded 1976
Sector Life Science
Revenue 215M USD (2015)
DESCRIPTION

WIL Research Co., Inc. is a global Contract Research Organization (CRO) that provides product safety toxicological research, bioanalytical, and formulation services to the pharmaceutical, biotechnology, chemical, agrochemical, and food products industries, as well as manufacturing support for clinical trials.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 3 of 3
Type: Add-on Acquisition M&A Deals 3 of 3
State: Illinois M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2009 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-01-01 QS Pharma

Boothwyn, Pennsylvania, United States

QS Pharma, LLC is a provider of a broad range of contract development/research and clinical/commercial manufacturing services for pharmaceutical and biopharmaceutical companies worldwide.

Buy -